Getinge Enters into Commercial Distribution Agreement with Cook Medical for iCast Covered Stent System in the United States
April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease. The agreement includes a 60-day transition period after which Cook Medical will assume the sales, marketing and distribution rights for the product in the United States. The iCast covered stent system will continue to be manufactured by Getinge’s legal entity Atrium Medical Corporation in Merrimack, NH. “This agreement with Cook Medical ensures that the iCast covered stent system will reach the optimal number of patients who will benefit from it in the United States,” said Patricia Fitch, President of Getinge NA. “This distribution agreement allows Getinge to best serve the U.S. market and accelerate our product innovation pipeline, in alignment with our global business strategy.” “This product fills the need of a cove